Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Glycomimetics Inc (GLYC)

Glycomimetics Inc (GLYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Glycomimetics Inc 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 USA

www.glycomimetics.com P: 240-243-1201 F: 301-738-2137

Description:

GlycoMimetics, Inc. is a biotechnology company. The company focused on the discovery and development of novel glycomimetic drugs to address diseases in which carbohydrate biology plays a key role. It product pipeline includes GMI-170, GMI-1271, E-selectin and CXCR4 antagonist, GMI-1051 and GMI-1070 at different clinical phases. GlycoMimetics, Inc. is based in Gaithersburg, United States.

Key Statistics

Overview:

Market Capitalization, $K 118,266
Enterprise Value, $K 76,476
Shares Outstanding, K 64,450
Annual Sales, $ 10 K
Annual Net Income, $ -36,900 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -9,080 K
EBIT, $ -39,280 K
EBITDA, $ -39,130 K
60-Month Beta 2.18
% of Insider Shareholders 8.70%
% of Institutional Shareholders 75.19%
Float, K 58,843
% Float 91.30%
Short Volume Ratio 0.82

Growth:

1-Year Return 32.86%
3-Year Return -23.54%
5-Year Return -85.28%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 50.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 03/27/24
Latest Earnings Date 05/01/24
Earnings Per Share ttm -0.58
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 26.32%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

GLYC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -73.09%
Return-on-Assets % -64.38%
Profit Margin % -369,000.02%
Debt/Equity 0.00
Price/Sales 11,601.00
Price/Cash Flow N/A
Price/Book 3.23
Book Value/Share 0.60
Interest Coverage -0.92
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar